<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 06-Aug-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (2025-08-06)</h1>
<hr />
<h2>Top News Highlights</h2>
<ul>
<li>
<p><strong>US Politics &amp; Global Affairs</strong></p>
<ul>
<li>Putin and Trump’s envoy met in Moscow amid US pressure for a Ukraine ceasefire; sanctions threat looms.</li>
<li>Trump threatens federal control of D.C. after attack on staffer and continues to escalate “debanking” grievances against major banks.</li>
<li>House Committee subpoenas Epsteins’ files; Bill and Hillary Clinton targeted in new congressional probe.</li>
</ul>
</li>
<li>
<p><strong>Domestic Policy and Legal</strong></p>
<ul>
<li>Texas and California battle over redistricting; Voting Rights Act faces new threats on its 60th anniversary.</li>
<li>RFK Jr. cancels $500M in mRNA vaccine contracts, signaling a possible turn in US vaccine and biotech policy.</li>
</ul>
</li>
<li>
<p><strong>Sector News</strong></p>
<ul>
<li>4 European countries jointly purchase $1B of US weapons for Ukraine; further large-scale NATO/EU arms deals under discussion.</li>
<li>Disney beats expectations with streaming, parks, and new NFL/WWE/ESPN mega-deals.</li>
<li>McDonald’s and several tech and entertainment names posting strong earnings, with markets shrugging off tariff fears.</li>
</ul>
</li>
<li>
<p><strong>Global Health &amp; Environment</strong></p>
<ul>
<li>Chikungunya and Legionnaires’ outbreaks reported in China and Harlem, respectively; rising Vibrio cases in the US.</li>
<li>Japan marks 80th year since Hiroshima; nuclear risk, environment, and energy themes remain in focus.</li>
</ul>
</li>
</ul>
<hr />
<h2>Macro &amp; Market Outlook</h2>
<h3>Economic Cycle &amp; Policy</h3>
<ul>
<li><strong>Recession Risk</strong>: Odds of a US recession this year remain moderate-to-low, while global growth is not immune to shocks (e.g., commodity/energy, policy errors, geopolitics).</li>
<li><strong>GDP &amp; Growth</strong>: Baseline US growth for 2025 is expected to muddle along at or just below 2%. Substantial upside or downside remains unlikely absent a major shock.</li>
<li><strong>Labor Market</strong>: Unemployment is expected to rise gradually but is not at crisis levels; job growth is softening and jobless claims are edging higher. Wage growth likely outpaces headline inflation, helping buffer consumer demand.</li>
<li><strong>Inflation &amp; Fed</strong>: US inflation is widely expected to stay above 3%, with limited relief in the short term. While the bulk of rate cuts will be modest (1–2), the path of cuts is shallow and rates are projected to remain in the 3–4%+ range through 2025. Emergency actions are seen as unlikely absent a major shock.</li>
<li><strong>US Dollar &amp; Trade</strong>: The USD is expected to weaken modestly, but not collapse. Retaliatory tariffs (notably from China, India, Brazil, Russia, and the EU) may complicate US trade and FX dynamics.</li>
</ul>
<h3>Fiscal, Debt, and Government Policy</h3>
<ul>
<li><strong>Deficits &amp; Debt</strong>: US government spending continues to rise, with national debt set to hit another record. Major spending cuts or deficit improvement are improbable in the near term.</li>
<li><strong>Tariffs and Trade Agreements</strong>: High probability that new tariffs will be imposed, especially targeting semiconductors, pharma, and commodities. Some US trade deals are at risk/revision and global trade tensions remain high, risking second-order impacts on input prices and sectoral supply chains.</li>
</ul>
<h3>Geopolitical Hotspots</h3>
<ul>
<li><strong>Ukraine/Russia</strong>: Sanctions and weapons deals continue, but the direct risk of NATO or US military escalation remains limited near term.</li>
<li><strong>China</strong>: Lower probability of outright military conflict (e.g., with the Philippines), but escalating trade and technology disputes remain a market concern.</li>
<li><strong>Emerging Markets</strong>: Potential for instability or snap elections (including in the Bahamas, Venezuela-Guyana tensions, etc.) but base case is continued status quo.</li>
</ul>
<hr />
<h2>Sector Themes</h2>
<h3>Energy, Commodities &amp; Climate</h3>
<ul>
<li><strong>Fossil Fuels</strong>: Oil and gas are expected to remain dominant in the global energy mix at least through 2030. Coal and oil use, while sticky, face slow attrition. Natural gas prices expected to rise in 2025.</li>
<li><strong>Renewables &amp; Climate</strong>: The world is on track to overshoot 2°C warming pre-2050, signaling intensifying pressure for adaptation and abrupt regulatory shifts ahead. US and EU climate goals face major headwinds; India likely to deliver more on targets, aided by policy tailwinds. Solar buildout in the US continues but at a modest rate (no explosive acceleration).</li>
<li><strong>Tariffs/Policy</strong>: Imminent tariffs on copper and broader US-China/EU trade friction to hit industrial metals, semis, and energy sectors.</li>
<li><strong>Insurance/Housing</strong>: Elevated, but not crisis-level, risk for major natural disasters (California earthquake, supervolcano) over the next decade. Insurance and REITs remain exposed to regional catastrophe risk, but near-term tail risks are modest.</li>
</ul>
<h3>Financials, Bonds &amp; Crypto</h3>
<ul>
<li><strong>Rates &amp; Bonds</strong>: With only light Fed easing expected, higher-for-longer yield curves are likely. Persistent debt growth and deficit concerns keep longer-term duration exposed to inflation and supply risks. Credit and MBS tied to Fannie/Freddie conservatorship remain closely watched.</li>
<li><strong>Crypto</strong>: Mass adoption continues; corporate embrace of Bitcoin sets the stage for further price volatility. Further upside possible in core assets (BTC, ETH) but froth emerges at the margin. Downside for legacy coins (e.g., Litecoin) is a risk.</li>
<li><strong>De-Dollarization</strong>: Incremental, not abrupt—USD’s share of reserves and trade may decline, but FX volatility will be event-driven.</li>
</ul>
<h3>Technology &amp; Industrials</h3>
<ul>
<li><strong>Semiconductors &amp; Tech</strong>: Semiconductor tariffs are almost certain this year—expect supply chain disruptions, margin pressure, and select reshoring opportunities. NVIDIA is likely to remain the world’s largest company by year-end, benefitting from AI/ML and sovereign, enterprise, and networking demand. Other megacaps (MSFT, AAPL, AMZN, GOOGL, TSLA) face increasing antitrust and regulatory scrutiny but low CEO turnover risk.</li>
<li><strong>Autonomous &amp; EVs</strong>: Non-linear path for mass commercialization of robotaxis, but EV market share will continue to rise (well above 30% by 2030). Tesla and peers may see regulatory action but near-term model launches/price cuts are less likely.</li>
<li><strong>Cloud &amp; AI</strong>: Robust SaaS momentum and AI infrastructure buildout (Oracle, AMD, NVDA) drive enterprise spend. Oracle continues to shift to multicloud and AI/data center themes.</li>
</ul>
<h3>Healthcare &amp; Biotech</h3>
<ul>
<li><strong>Regulation</strong>: Psychedelic therapies could see approval, but a Type 1 diabetes cure remains unlikely this decade.</li>
<li><strong>Drug Pipeline</strong>: Multiple high-probability FDA approvals (Elinzanetant, Donidalorsen, Bumetanide nasal spray, Sebetralstat) offer select opportunities for biotech.</li>
<li><strong>Healthcare Policy</strong>: Major changes to Obamacare, drug pricing, or benefit structures unlikely before 2029.</li>
<li><strong>Emerging Risks</strong>: Outbreaks (Legionnaires’, chikungunya, Vibrio) and early-age cancer trends highlight potential idiosyncratic headwinds for public health and insurance sectors.</li>
</ul>
<h3>Consumer/Media</h3>
<ul>
<li><strong>Entertainment/Media</strong>: Disney, via ESPN and new streaming/UFC/NFL deals, is strengthening its franchise in the industry, offsetting linear TV headwinds. AMC shifts focus to consumer experience amid box office volatility. Video game/franchise launches (Elder Scrolls VI) continue to draw sector attention.</li>
<li><strong>Consumer</strong>: Firms with strong pricing power (McDonald’s, Apple through back-to-school sales) outperform amid cost-of-living pressures.</li>
</ul>
<hr />
<h2>Notable Individual Names</h2>
<ul>
<li><strong>Disney (DIS)</strong>: Strong content/franchise monetization, new sports/streaming/NFL deals shore up near-term prospects.</li>
<li><strong>NVIDIA (NVDA)</strong>: AI and data center tailwinds continue, expected to lead market cap rankings by year-end.</li>
<li><strong>Apple (AAPL), Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN)</strong>: Heavy regulatory headwinds but stable leadership; antitrust outcomes could impact structure/valuation of core businesses.</li>
<li><strong>Tesla (TSLA)</strong>: EV growth intact; regulatory risk rising but no near-term breakthrough on low-cost models or robotaxi mass deployment.</li>
<li><strong>Oracle (ORCL), AMD</strong>: AI, cloud, and SaaS themes persist, but supply chain/geopolitical risk increasingly salient.</li>
<li><strong>Palantir (PLTR)</strong>: Growth likely led by government, defense, and AI/automation contracts; valuation is high but execution strong.</li>
</ul>
<hr />
<h2>Key Takeaways &amp; Investment Approach</h2>
<ul>
<li>Macro backdrop remains “higher-for-longer” rates, with gradual inflation and modest growth. Let bond durations skew short/intermediate with some inflation protection.</li>
<li>Technology, energy, and defense remain high-conviction multi-year themes, but watch for cyclical swings in response to tariffs, policy, and international disruption.</li>
<li>Remain agile in positioning for FX/trade shocks, and expect greater sector and security dispersion with regulatory and geopolitical crosscurrents.</li>
<li>Stay alert to healthcare events—approvals/epidemics will cause idiosyncratic volatility, notably for insurance, pharma, and consumer health stocks.</li>
<li>Monitor climate/energy legislation and catastrophe risk as forward-looking signals for insurance, real assets, and infrastructure.</li>
</ul>
<hr />
<p><strong>Prepared for: Macro-informed, US-centric, cross-asset investor</strong></p>

</main>
</body>
</html>
